Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMTX
#4420
Immatics N.V. - Ordinary Shares
0.1
2
USD
-98.99%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-98.99%
Monthly Change
-98.98%
6 month change
-98.90%
Year Change
-98.89%
Previous Close
11.4
5
Open
0.1
2
Low
0.1
1
High
0.1
2
Volume
34
Markets
US Stock Market
Healthcare
IMTX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q4, 25
TTM
Cash from operating activities
—
—
—
Cash from investing activities
—
—
—
Cash from financing activities
—
—
—
Free cash flow
—
—
—
News
Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy
NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up
Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)
Immatics NV earnings beat by €0.13, revenue topped estimates
Nuvation Bio Inc. (NUVB) Reports Q4 Loss, Beats Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates